Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1996 Nov;59(5):1134–1148.

The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families.

J A Noble 1, A M Valdes 1, M Cook 1, W Klitz 1, G Thomson 1, H A Erlich 1
PMCID: PMC1914851  PMID: 8900244

Abstract

We report here our analysis of HLA class II alleles in 180 Caucasian nuclear families with at least two children with insulin-dependent diabetes mellitus (IDDM). DRB1, DQA1, DQB1, and DPB1 genotypes were determined with PCR/sequence-specific oligonucleotide probe typing methods. The data allowed unambiguous determination of four-locus haplotypes in all but three of the families. Consistent with other studies, our data indicate an increase in DR3/DR4, DR3/DR3, and DR4/DR4 genotypes in patients compared to controls. In addition, we found an increase in DR1/DR4, DR1/DR3, and DR4/DR8 genotypes. While the frequency of DQB1*0302 on DR4 haplotypes is dramatically increased in DR3/DR4 patients, DR4 haplotypes in DR1/DR4 patients exhibit frequencies of DQB1*0302 and DQB1*0301 more closely resembling those in control populations. The protective effect of DR2 is evident in this data set and is limited to the common DRB1*1501-DQB1*0602 haplotype. Most DR2+ patients carry the less common DR2 haplotype DRB1*1601-DQB1*0502, which is not decreased in patients relative to controls. DPB1 also appears to play a role in disease susceptibility. DPB1*0301 is increased in patients (P < .001) and may contribute to the disease risk of a number of different DR-DQ haplotypes. DPB1*0101, found almost exclusively on DR3 haplotypes in patients, is slightly increased, and maternal transmissions of DRB1*0301-DPB1*0101 haplotypes to affected children occur twice as frequently as do paternal transmissions. Transmissions of DR3 haplotypes carrying other DPB1 alleles occur at approximately equal maternal and paternal frequencies. The complex, multigenic nature of HLA class II-associated IDDM susceptibility is evident from these data.

Full text

PDF
1134

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awata T., Kuzuya T., Matsuda A., Iwamoto Y., Kanazawa Y. Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia. 1992 May;35(5):419–424. doi: 10.1007/BF02342437. [DOI] [PubMed] [Google Scholar]
  2. Bain S. C., Rowe B. R., Barnett A. H., Todd J. A. Parental origin of diabetes-associated HLA types in sibling pairs with type I diabetes. Diabetes. 1994 Dec;43(12):1462–1468. doi: 10.2337/diab.43.12.1462. [DOI] [PubMed] [Google Scholar]
  3. Begovich A. B., McClure G. R., Suraj V. C., Helmuth R. C., Fildes N., Bugawan T. L., Erlich H. A., Klitz W. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol. 1992 Jan 1;148(1):249–258. [PubMed] [Google Scholar]
  4. Bell G. I., Horita S., Karam J. H. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes. 1984 Feb;33(2):176–183. doi: 10.2337/diab.33.2.176. [DOI] [PubMed] [Google Scholar]
  5. Blackwelder W. C., Elston R. C. A comparison of sib-pair linkage tests for disease susceptibility loci. Genet Epidemiol. 1985;2(1):85–97. doi: 10.1002/gepi.1370020109. [DOI] [PubMed] [Google Scholar]
  6. Bodmer J. G., Marsh S. G., Albert E. D., Bodmer W. F., Bontrop R. E., Charron D., Dupont B., Erlich H. A., Mach B., Mayr W. R. Nomenclature for factors of the HLA system, 1995. Tissue Antigens. 1995 Jul;46(1):1–18. doi: 10.1111/j.1399-0039.1995.tb02470.x. [DOI] [PubMed] [Google Scholar]
  7. Bugawan T. L., Begovich A. B., Erlich H. A. Rapid HLA-DPB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes. Immunogenetics. 1990;32(4):231–241. doi: 10.1007/BF00187094. [DOI] [PubMed] [Google Scholar]
  8. Bugawan T. L., Erlich H. A. Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA. Immunogenetics. 1991;33(3):163–170. doi: 10.1007/BF01719235. [DOI] [PubMed] [Google Scholar]
  9. Bugawan T. L., Horn G. T., Long C. M., Mickelson E., Hansen J. A., Ferrara G. B., Angelini G., Erlich H. A. Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-alpha and DP-beta loci. J Immunol. 1988 Dec 1;141(11):4024–4030. [PubMed] [Google Scholar]
  10. Caillat-Zucman S., Garchon H. J., Timsit J., Assan R., Boitard C., Djilali-Saiah I., Bougnères P., Bach J. F. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest. 1992 Dec;90(6):2242–2250. doi: 10.1172/JCI116110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Clerget-Darpoux F., Babron M. C., Deschamps I., Hors J. Complementation and maternal effect in insulin-dependent diabetes. Am J Hum Genet. 1991 Jul;49(1):42–48. [PMC free article] [PubMed] [Google Scholar]
  12. Copeman J. B., Cucca F., Hearne C. M., Cornall R. J., Reed P. W., Rønningen K. S., Undlien D. E., Nisticò L., Buzzetti R., Tosi R. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet. 1995 Jan;9(1):80–85. doi: 10.1038/ng0195-80. [DOI] [PubMed] [Google Scholar]
  13. Cucca F., Lampis R., Frau F., Macis D., Angius E., Masile P., Chessa M., Frongia P., Silvetti M., Cao A. The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci. Hum Immunol. 1995 Aug;43(4):301–308. doi: 10.1016/0198-8859(95)00042-3. [DOI] [PubMed] [Google Scholar]
  14. Cucca F., Muntoni F., Lampis R., Frau F., Argiolas L., Silvetti M., Angius E., Cao A., De Virgiliis S., Congia M. Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol. 1993 Jun;37(2):85–94. doi: 10.1016/0198-8859(93)90146-r. [DOI] [PubMed] [Google Scholar]
  15. Cudworth A. G., Woodrow J. C. Letter: HL-A antigens and diabetes mellitus. Lancet. 1974 Nov 9;2(7889):1153–1153. doi: 10.1016/s0140-6736(74)90930-1. [DOI] [PubMed] [Google Scholar]
  16. Davies J. L., Kawaguchi Y., Bennett S. T., Copeman J. B., Cordell H. J., Pritchard L. E., Reed P. W., Gough S. C., Jenkins S. C., Palmer S. M. A genome-wide search for human type 1 diabetes susceptibility genes. Nature. 1994 Sep 8;371(6493):130–136. doi: 10.1038/371130a0. [DOI] [PubMed] [Google Scholar]
  17. Deschamps I., Hors J., Clerget-Darpoux F., Gardais E., Robert J. J., Marcelli-Berge A., Lestradet H., Dausset J. Excess of maternal HLA-DR3 antigens in HLA DR3,4 positive type 1 (insulin-dependent) diabetic patients. Diabetologia. 1990 Jul;33(7):425–430. doi: 10.1007/BF00404094. [DOI] [PubMed] [Google Scholar]
  18. Easteal S., Kohonen-Corish M. R., Zimmet P., Serjeantson S. W. HLA-DP variation as additional risk factor in IDDM. Diabetes. 1990 Jul;39(7):855–857. doi: 10.2337/diab.39.7.855. [DOI] [PubMed] [Google Scholar]
  19. Erlich H. A., Bugawan T. L., Scharf S., Nepom G. T., Tait B., Griffith R. L. HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes. 1990 Jan;39(1):96–103. doi: 10.2337/diacare.39.1.96. [DOI] [PubMed] [Google Scholar]
  20. Erlich H. A., Griffith R. L., Bugawan T. L., Ziegler R., Alper C., Eisenbarth G. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes. Diabetes. 1991 Apr;40(4):478–481. doi: 10.2337/diab.40.4.478. [DOI] [PubMed] [Google Scholar]
  21. Erlich H. A. HLA class II sequences and genetic susceptibility to insulin dependent diabetes mellitus. Baillieres Clin Endocrinol Metab. 1991 Sep;5(3):395–411. doi: 10.1016/s0950-351x(05)80138-7. [DOI] [PubMed] [Google Scholar]
  22. Erlich H. A., Rotter J. I., Chang J. D., Shaw S. J., Raffel L. J., Klitz W., Bugawan T. L., Zeidler A. Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes. 1996 May;45(5):610–614. doi: 10.2337/diab.45.5.610. [DOI] [PubMed] [Google Scholar]
  23. Erlich H. A., Zeidler A., Chang J., Shaw S., Raffel L. J., Klitz W., Beshkov Y., Costin G., Pressman S., Bugawan T. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet. 1993 Apr;3(4):358–364. doi: 10.1038/ng0493-358. [DOI] [PubMed] [Google Scholar]
  24. Erlich H., Bugawan T., Begovich A. B., Scharf S., Griffith R., Saiki R., Higuchi R., Walsh P. S. HLA-DR, DQ and DP typing using PCR amplification and immobilized probes. Eur J Immunogenet. 1991 Feb-Apr;18(1-2):33–55. doi: 10.1111/j.1744-313x.1991.tb00005.x. [DOI] [PubMed] [Google Scholar]
  25. Erlich H., Bugawan T., Begovich A., Scharf S. Analysis of HLA class II polymorphism using polymerase chain reaction. Arch Pathol Lab Med. 1993 May;117(5):482–485. [PubMed] [Google Scholar]
  26. Field L. L. Non-HLA region genes in insulin dependent diabetes mellitus. Baillieres Clin Endocrinol Metab. 1991 Sep;5(3):413–438. doi: 10.1016/s0950-351x(05)80139-9. [DOI] [PubMed] [Google Scholar]
  27. Field L. L., Tobias R., Magnus T. A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin-dependent diabetes mellitus. Nat Genet. 1994 Oct;8(2):189–194. doi: 10.1038/ng1094-189. [DOI] [PubMed] [Google Scholar]
  28. Fohlman J., Friman G. Is juvenile diabetes a viral disease? Ann Med. 1993 Dec;25(6):569–574. [PubMed] [Google Scholar]
  29. Hashimoto L., Habita C., Beressi J. P., Delepine M., Besse C., Cambon-Thomsen A., Deschamps I., Rotter J. I., Djoulah S., James M. R. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature. 1994 Sep 8;371(6493):161–164. doi: 10.1038/371161a0. [DOI] [PubMed] [Google Scholar]
  30. Horn G. T., Bugawan T. L., Long C. M., Erlich H. A. Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci U S A. 1988 Aug;85(16):6012–6016. doi: 10.1073/pnas.85.16.6012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Horn G. T., Bugawan T. L., Long C. M., Manos M. M., Erlich H. A. Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals. Hum Immunol. 1988 Apr;21(4):249–263. doi: 10.1016/0198-8859(88)90034-1. [DOI] [PubMed] [Google Scholar]
  32. Hu C. Y., Allen M., Chuang L. M., Lin B. J., Gyllensten U. Association of insulin-dependent diabetes mellitus in Taiwan with HLA class II DQB1 and DRB1 alleles. Hum Immunol. 1993 Oct;38(2):105–114. doi: 10.1016/0198-8859(93)90526-7. [DOI] [PubMed] [Google Scholar]
  33. Huang H. S., Peng J. T., She J. Y., Zhang L. P., Chao C. C., Liu K. H., She J. X. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population. Hum Immunol. 1995 Dec;44(4):210–219. doi: 10.1016/0198-8859(95)00108-5. [DOI] [PubMed] [Google Scholar]
  34. Klitz W., Aldrich C. L., Fildes N., Horning S. J., Begovich A. B. Localization of predisposition to Hodgkin disease in the HLA class II region. Am J Hum Genet. 1994 Mar;54(3):497–505. [PMC free article] [PubMed] [Google Scholar]
  35. Louis E. J., Thomson G. Three-allele synergistic mixed model for insulin-dependent diabetes mellitus. Diabetes. 1986 Sep;35(9):958–963. doi: 10.2337/diab.35.9.958. [DOI] [PubMed] [Google Scholar]
  36. Luo D. F., Bui M. M., Muir A., Maclaren N. K., Thomson G., She J. X. Affected-sib-pair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am J Hum Genet. 1995 Oct;57(4):911–919. [PMC free article] [PubMed] [Google Scholar]
  37. Margaritte-Jeannin P., Clerget-Darpoux F., Hors J., Deschamps I. Testing parental imprinting in insulin-dependent diabetes mellitus by the marker-association-segregation-chi 2 method. Am J Hum Genet. 1995 May;56(5):1080–1087. [PMC free article] [PubMed] [Google Scholar]
  38. Nepom B. S., Schwarz D., Palmer J. P., Nepom G. T. Transcomplementation of HLA genes in IDDM. HLA-DQ alpha- and beta-chains produce hybrid molecules in DR3/4 heterozygotes. Diabetes. 1987 Jan;36(1):114–117. doi: 10.2337/diab.36.1.114. [DOI] [PubMed] [Google Scholar]
  39. Nepom G. T., Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol. 1991;9:493–525. doi: 10.1146/annurev.iy.09.040191.002425. [DOI] [PubMed] [Google Scholar]
  40. Nerup J., Platz P., Andersen O. O., Christy M., Lyngsoe J., Poulsen J. E., Ryder L. P., Nielsen L. S., Thomsen M., Svejgaard A. HL-A antigens and diabetes mellitus. Lancet. 1974 Oct 12;2(7885):864–866. doi: 10.1016/s0140-6736(74)91201-x. [DOI] [PubMed] [Google Scholar]
  41. Owerbach D., Gabbay K. H. The HOXD8 locus (2q31) is linked to type I diabetes. Interaction with chromosome 6 and 11 disease susceptibility genes. Diabetes. 1995 Jan;44(1):132–136. doi: 10.2337/diab.44.1.132. [DOI] [PubMed] [Google Scholar]
  42. Owerbach D., Gunn S., Gabbay K. H. Primary association of HLA-DQw8 with type I diabetes in DR4 patients. Diabetes. 1989 Jul;38(7):942–945. doi: 10.2337/diab.38.7.942. [DOI] [PubMed] [Google Scholar]
  44. Payami H., Joe S., Farid N. R., Stenszky V., Chan S. H., Yeo P. P., Cheah J. S., Thomson G. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet. 1989 Oct;45(4):541–546. [PMC free article] [PubMed] [Google Scholar]
  45. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet. 1987 Jan;40(1):1–14. [PMC free article] [PubMed] [Google Scholar]
  46. Rosenlicht J. W., Hartung K., Deicher H., Frey J. A novel HLA-DRB1-DR2 allele associated with HLA mistyping. Immunogenetics. 1993;37(6):479–479. doi: 10.1007/BF00222476. [DOI] [PubMed] [Google Scholar]
  47. Rotter J. I., Anderson C. E., Rubin R., Congleton J. E., Terasaki P. I., Rimoin D. L. HLA genotypic study of insulin-dependent diabetes the excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis. Diabetes. 1983 Feb;32(2):169–174. doi: 10.2337/diab.32.2.169. [DOI] [PubMed] [Google Scholar]
  48. Rønningen K. S., Gjertsen H. A., Iwe T., Spurkland A., Hansen T., Thorsby E. Particular HLA-DQ alpha beta heterodimer associated with IDDM susceptibility in both DR4-DQw4 Japanese and DR4-DQw8/DRw8-DQw4 whites. Diabetes. 1991 Jun;40(6):759–763. doi: 10.2337/diab.40.6.759. [DOI] [PubMed] [Google Scholar]
  49. Saiki R. K., Walsh P. S., Levenson C. H., Erlich H. A. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6230–6234. doi: 10.1073/pnas.86.16.6230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Scharf S. J., Griffith R. L., Erlich H. A. Rapid typing of DNA sequence polymorphism at the HLA-DRB1 locus using the polymerase chain reaction and nonradioactive oligonucleotide probes. Hum Immunol. 1991 Mar;30(3):190–201. doi: 10.1016/0198-8859(91)90034-7. [DOI] [PubMed] [Google Scholar]
  51. Schroeijers W. E., de Koster H. S., Verduyn W., Schreuder G. M., Termijtelen A. T-cell recognition of class II products that result from the combined presence of two different HLA haplotypes. Hum Immunol. 1992 Apr;33(4):229–234. doi: 10.1016/0198-8859(92)90329-l. [DOI] [PubMed] [Google Scholar]
  52. Sheehy M. J., Scharf S. J., Rowe J. R., Neme de Gimenez M. H., Meske L. M., Erlich H. A., Nepom B. S. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest. 1989 Mar;83(3):830–835. doi: 10.1172/JCI113965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Singal D. P., Blajchman M. A. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes. 1973 Jun;22(6):429–432. doi: 10.2337/diab.22.6.429. [DOI] [PubMed] [Google Scholar]
  54. Spielman R. S., Baur M. P., Clerget-Darpoux F. Genetic analysis of IDDM: summary of GAW5 IDDM results. Genet Epidemiol. 1989;6(1):43–58. doi: 10.1002/gepi.1370060111. [DOI] [PubMed] [Google Scholar]
  55. Tait B. D., Harrison L. C. Overview: the major histocompatibility complex and insulin dependent diabetes mellitus. Baillieres Clin Endocrinol Metab. 1991 Jun;5(2):211–228. doi: 10.1016/s0950-351x(05)80124-7. [DOI] [PubMed] [Google Scholar]
  56. Tait B. D., Mraz G., Harrison L. C. Association of HLA-DQw3 (TA10-) with type I diabetes occurs with DR3/4 but not DR1/4 patients. Diabetes. 1988 Jul;37(7):926–929. doi: 10.2337/diab.37.7.926. [DOI] [PubMed] [Google Scholar]
  57. Thomson G. Investigation of the mode of inheritance of the HLA associated diseases by the method of antigen genotype frequencies among diseased individuals. Tissue Antigens. 1983 Feb;21(2):81–104. doi: 10.1111/j.1399-0039.1983.tb00377.x. [DOI] [PubMed] [Google Scholar]
  58. Thomson G., Robinson W. P., Kuhner M. K., Joe S., Klitz W. HLA and insulin gene associations with IDDM. Genet Epidemiol. 1989;6(1):155–160. doi: 10.1002/gepi.1370060129. [DOI] [PubMed] [Google Scholar]
  59. Thomson G., Robinson W. P., Kuhner M. K., Joe S., MacDonald M. J., Gottschall J. L., Barbosa J., Rich S. S., Bertrams J., Baur M. P. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet. 1988 Dec;43(6):799–816. [PMC free article] [PubMed] [Google Scholar]
  60. Todd J. A., Bell J. I., McDevitt H. O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 1987 Oct 15;329(6140):599–604. doi: 10.1038/329599a0. [DOI] [PubMed] [Google Scholar]
  61. Todd J. A., Mijovic C., Fletcher J., Jenkins D., Bradwell A. R., Barnett A. H. Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature. 1989 Apr 13;338(6216):587–589. doi: 10.1038/338587a0. [DOI] [PubMed] [Google Scholar]
  62. Trucco M., LaPorte R. Exposure to superantigens as an immunogenetic explanation of type I diabetes mini-epidemics. J Pediatr Endocrinol Metab. 1995 Jan-Mar;8(1):3–10. doi: 10.1515/jpem.1995.8.1.3. [DOI] [PubMed] [Google Scholar]
  63. Undlien D. E., Akselsen H. E., Joner G., Dahl-Jorgensen K., Aagenaes O., Sovik O., Thorsby E., Rønningen K. S. No difference in the parental origin of susceptibility HLA class II haplotypes among Norwegian patients with insulin-dependent diabetes mellitus. Am J Hum Genet. 1995 Dec;57(6):1511–1514. [PMC free article] [PubMed] [Google Scholar]
  64. Vadheim C. M., Rotter J. I., Maclaren N. K., Riley W. J., Anderson C. E. Preferential transmission of diabetic alleles within the HLA gene complex. N Engl J Med. 1986 Nov 20;315(21):1314–1318. doi: 10.1056/NEJM198611203152103. [DOI] [PubMed] [Google Scholar]
  65. WOOLF B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955 Jun;19(4):251–253. doi: 10.1111/j.1469-1809.1955.tb01348.x. [DOI] [PubMed] [Google Scholar]
  66. de Koster H. S., van Rood J. J., Termijtelen A. HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing. Eur J Immunol. 1992 Jun;22(6):1531–1539. doi: 10.1002/eji.1830220628. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES